ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,971Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 2056

$572K Total Retail Price of All Prescriptions

Rank: 37 out of 2056

427 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 427 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

13% of this provider’s 427 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

3% of this provider’s 10,429 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
OMEPRAZOLE 474 414 1 4
LEVOTHYROXINE SODIUM 446 403 2 3
SIMVASTATIN 379 328 3 2
CRESTOR 327 314 4 30
METFORMIN HCL 293 259 5 8
CITALOPRAM HBR 280 223 6 15
LISINOPRIL 271 237 7 1
WARFARIN SODIUM 255 250 8 12
GABAPENTIN 233 191 9 14
POTASSIUM CHLORIDE 233 216 9 18
HYDROCODONE-ACETAMINOPHEN 232 164 S3 11 5
AMLODIPINE BESYLATE 216 192 12 6
TAMSULOSIN HCL 200 191 13 28
LOSARTAN POTASSIUM 196 177 14 13
ATORVASTATIN CALCIUM 192 178 15 17
FLUOXETINE HCL 182 174 16 33
PRAVASTATIN SODIUM 180 166 17 20
CARVEDILOL 176 161 18 35
FUROSEMIDE 174 157 19 9
METOPROLOL TARTRATE 167 152 20 11
ATENOLOL 152 135 21 10
AMITRIPTYLINE HCL 147 85 R 22 60
DIGOXIN 143 136 23 53
ENALAPRIL MALEATE 116 116 24 73
METOPROLOL SUCCINATE 108 108 25 19
NABUMETONE 105 87 26 176
BUPROPION HCL SR 101 63 27 104
RANITIDINE HCL 101 89 27 22
ALLOPURINOL 93 80 29 32
NAMENDA 92 92 30 62
CYCLOBENZAPRINE HCL 91 71 R 31 52
LOSARTAN-HYDROCHLOROTHIAZIDE 89 79 32 78
OXYCODONE-ACETAMINOPHEN 85 81 S2 33 40
DONEPEZIL HCL 84 84 34 37
CLOPIDOGREL 84 78 34 72
DILTIAZEM 24HR CD 81 52 36 120
FINASTERIDE 81 81 36 90
OXYCODONE HCL 79 46 S2 38 24
HYDROCHLOROTHIAZIDE 78 67 39 7
TRIAMTERENE-HCTZ 78 64 39 46
ROPINIROLE HCL 75 57 41 98
PROAIR HFA 72 55 42 29
TRIAMCINOLONE ACETONIDE 72 66 42 81
SPIRIVA 70 59 44 42
GLIMEPIRIDE 67 59 45 67
ZOLPIDEM TARTRATE 64 57 46 23
CEPHALEXIN 62 54 47 125
FLUTICASONE PROPIONATE 62 56 47 31
VENLAFAXINE HCL ER 61 29 49 82
BENAZEPRIL HCL 60 54 50 74
TRAZODONE HCL 60 43 50 21
PLAVIX 60 51 50 131
PANTOPRAZOLE SODIUM 59 46 53 55
ALENDRONATE SODIUM 57 57 54 26
AVODART 56 56 55 195
METHADONE HCL 56 44 S2 55 49
POLYETHYLENE GLYCOL 3350 54 52 57 50
TERAZOSIN HCL 52 42 58 106
GLIPIZIDE XL 52 52 58 159
PREDNISONE 52 45 58 38
LIPITOR 51 47 61 146
MIRTAZAPINE 50 37 62 45
ENALAPRIL-HYDROCHLOROTHIAZIDE 50 46 62 361
ZETIA 50 49 62 122
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 23, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.